Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing
2025 · 4th Quarter (Oct 1 - Dec 31)
QUEST DIAGNOSTICS INCORPORATED
Filed by QUEST DIAGNOSTICS INCORPORATED.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- Not reported
- Expenses
- $350,000.00
- Registrant
- QUEST DIAGNOSTICS INCORPORATED
- Filing UUID
- 15074fd7-e452-42f2-965d-f078a053018c
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation S. 2355 and H.R. 5582 - Patients Deserve Price Tags Act S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 Diagnostics and chronic disease prevention and treatment
Literal federal measure citations: S. 2355, H.R. 5582, S.1816, H.R. 3514
S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program Regulatory changes to Sec. 216 of the Protecting Access to Medicare Act of 2014 (PAMA)
Literal federal measure citations: S.2761, H.R. 5269, H.R. 5571
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.